[1] 王宝玲,周连新. 螺旋CT、能谱CT和MRI诊断原发性肝癌的临床价值比较. 实用肝脏病杂志,2016,19(4):467-470. [2] Zhao F,Lu PX,Yan SX,et al.CT and MR features of xanthogranulomatous cholecystitis:an analysis of consecutive 49 cases. Eur J Rad,2013,82(9):1391-1397. [3] Liu JJ,Li HX,Chen ZB,et al.Consistency analysis of contrast-enhanced ultrasound and contrast-enhanced CT in diagnosis of small hepatocellular carcinoma. Int J Clin Exp Med,2015,8(11):21466-21471. [4] Bruegel M,Muenzel D,Waldt S,et al.Hepatic angiosarcoma: cross-sectional imaging findings in seven patients with emphasis on dynamic contrast-enhanced and diffusion-weighted MRI. Abdom Imaging,2013,38(4):745-754. [5] 刘振国,强永乾. 螺旋CT 和MRI 对肝内周围型胆管癌诊断价值分析. 实用肝脏病杂志,2016,19(5):591-594. [6] Bttcher J,Hansch A,Pfeil A,et al.Detection and classification of different liver lesions:Comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation. Eur J Radiol,2013,82(11):1860-1869. [7] Park SK,Lee IS,Choi JY,et al.CT and MRI of fibrous dysplasia of the spine. Br J Radiol,2012,85(1015):996-1001. [8] Ma C,Liu A,Wang Y,et al.The hepatocyte phase of Gd-EOB-DTPA-enhanced MRI in the evaluation of hepatic fibrosis and early liver cirrhosis in a rat model:an experimental study. Life Sci,2014,108(2):104-108. [9] Park YS,Lee CH,Kim BH,et al.Using Gd-EOB-DTPA-enhanced 3-T MRI for the differentiation of infiltrative hepatocellular carcinoma and focal confluent fibrosis in liver cirrhosis. Mag Res Imaging,2013,31(7):1137-1142 [10] Sundarakumar D K,Wilson G J,Osman S F,et al.Evaluation of image registration in subtracted 3D dynamic contrast-enhanced MRI of treated hepatocellular carcinoma. Am J Roentgenol,2015,204(2):287-296. [11] Dong AS,Dong H,Zuo CJ,et al.Diffuse infantile hepatic hemangioendothelioma with early central enhancement in an adult: A case report of CT and MRI findings. Medicine (Baltimore),2015,94(51):e2353. [12] Bilgin M,Yildiz S,Toprak H,et al.CT and MRI findings of hepatic involvement in rendu-osler-weber disease. Case Rep Rad,2012,2012(6):484085. [13] Kurucay M,Kloth C,Kaufmann S,et al.Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT:which parameters work best Cancer Imaging,2017,17(1):18. [14] Quaia E,De P L,Pizzolato R,et al.Predictors of dysplastic nodule diagnosis in patients with liver cirrhosis on unenhanced and gadobenate dimeglumine-enhanced MRI with dynamic and hepatobiliary phase. AJR,2013,200(3):553-562. [15] Ghanaati H,Alavian S M,Jafarian A,et al.Imaging and imaging-guided interventions in the diagnosis and management of hepatocellular carcinoma (HCC)-review of evidence. Iran J Radiol,2012,9(4):167-177. [16] Campos JT,Sirlin CB,Choi JY.Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI:the atlas. Insights imaging,2012,3(5):451-474. [17] Jeon I,Cho E S,Kim J H,et al.Feasibility of 10-minute delayed hepatocyte phase imaging using a 30°flip angle in Gd-EOB-DTPA-enhanced liver MRI for the detection of hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis. Plos One,2016,11(12):e0167701. [18] Ding Y,Rao SX,Chen CZ,et al.Assessing liver function in patients with HBV-related HCC:a comparison of T 1,mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI. Eur Radiol, 2015,25(5):1392-1398. [19] Zhou ZP,Long LL,Qiu WJ,et al.Evaluating segmental liver function using T1 mapping on Gd-EOB-DTPA-enhanced MRI with a 3.0 Tesla. Bmc Med Imaging,2017,17(1):20. [20] Kobayashi S,Matsui O,Gabata T,et al.Intrahepatic periportal high intensity on hepatobiliary phase images of Gd-EOB-DTPA-enhanced MRI:imaging findings and prevalence in various hepatobiliary diseases. Jpn J Radiol,2013,31(1):9-15. [21] 赵年,李春华,李德秀,等. MRI与CT多期动态增强扫描诊断肝硬化伴肝癌的效果比较. 中国CT和MRI杂志,2017,15(5):85-87. |